Biomolecules (Mar 2023)

Association of Serum Vaspin Concentration with Metabolic Disorders in Obese Individuals

  • Łukasz Pilarski,
  • Marta Pelczyńska,
  • Anna Koperska,
  • Agnieszka Seraszek-Jaros,
  • Monika Szulińska,
  • Paweł Bogdański

DOI
https://doi.org/10.3390/biom13030508
Journal volume & issue
Vol. 13, no. 3
p. 508

Abstract

Read online

Vaspin, a molecule produced in visceral adipose tissue, seems to participate in the pathogenesis of metabolic disorders. The study aimed to determine the association of vaspin concentration with metabolic disorders in obese individuals. Forty obese patients and twenty normal-weight subjects underwent biochemical (fasting glucose, insulin, lipid profile, interleukin-6, hs-CRP, vaspin concentration), blood pressure, and anthropometric measurements. The HOMA-IR index was calculated. Serum vaspin concentrations in the obese group were significantly higher than in the control group (0.82 ± 0.62 vs. 0.43 ± 0.59; p p = 0.0338). An elevated vaspin level may imply its compensatory role against metabolic disorders in obese patients. Thus, vaspin appears to be a useful diagnostic parameter for new therapeutic approaches in obesity-related complications. Nevertheless, due to the small sample size, further studies are needed to confirm our results.

Keywords